Evidence map›Paper›PMID 41572270›Full record

ArticleMicrobial cell factories2026

Gold nanoparticle-mediated metabolic engineering in Trichoderma longibrachiatum MD33 unveils a hybrid terpenoid-alkaloid pathway for enhanced dendrobine biosynthesis.

Surendra Sarsaiya, Archana Jain, Jishuang Chen, Qihai Gong

Abstract read
In one paragraph

Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Surendra Sarsaiya *Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, 563003, China. sarsaiya.s@gmail.com.
Archana Jain *Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, 563003, China.
Jishuang ChenBioresource Institute for Healthy Utilization, Zunyi Medical University, Zunyi, 563003, China. bihu_zmu@zmu.edu.cn.
Qihai GongKey Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, 563003, China. gqh@zmu.edu.cn.

Funding

Guizhou Science and Technology Corporation Platform Talents Fund [2017]5733-001 and CK-1130-002High Level Talent Project Fund of Zunyi Medical University 1092/2000006)F-1092National Natural Science Foundation of China 82373981
6 · The paper itself

Abstract

backgroundDendrobine, a neuroprotective and anticancer sesquiterpenic alkaloid, is primarily sourced from endangered Dendrobium orchids, posing sustainability challenges to its production. Endophytic fungi, such as Trichoderma longibrachiatum MD33, offer an alternative; however, unresolved biosynthetic pathways and low yields hinder industrial scalability. Enhancing fungal metabolism through nanotechnology could address these limitations; however, nanoparticle-mediated engineering remains unexplored for dendrobine biosynthesis. This study aimed to (1) optimize dendrobine production in T. longibrachiatum MD33 using gold nanoparticles (CH-AuNPs) functionalized with alkaloid precursors and (2) elucidate the biosynthetic pathway to enable targeted metabolic engineering. CH-AuNPs were chemically synthesized, functionalized with L-phenylalanine, L-tyrosine, and tyramine, and applied to fungal cultures at concentrations of 0.5-20.0 mg/L. Multi-omics analyses (transcriptomics, proteomics, and metabolomics) identified pathway enzymes, and oxidative stress markers and dendrobine yields were quantified.

resultsDose-dependent CH-AuNP exposure (10.0 mg/L optimal) elevated dendrobine production by 63.7%, balancing pathway activation and oxidative stress. Multi-omics analysis revealed a hybrid terpenoid-alkaloid pathway, wherein sesquiterpene scaffolds from the mevalonate pathway merge with ornithine-derived piperidine moieties. This process is regulated by sesquiterpene synthases (TPS), cytochrome P450s (CYP71D1), and O-methyltransferases (COMT). Metabolomic analysis provided direct evidence for the rechanneling of nitrogen metabolism, with depletion of glutamate and ornithine pools and accumulation of polyamine pathway intermediates such as putrescine, supporting the transcriptional upregulation of ornithine decarboxylase (ODC). Mechanistically, low-to-moderate oxidative stress induced by CH-AuNPs activated redox-sensitive transcription factors and stress-responsive pathways, which in turn upregulated terpenoid and alkaloid biosynthesis genes. This controlled stress response enhanced precursor flux and enzyme activity, leading to increased dendrobine synthesis without triggering cellular damage in the cells. Concentrations > 10.0 mg/L suppressed metabolism owing to oxidative damage.

conclusionsCH-AuNPs act as precision tools to upregulate dendrobine biosynthesis in T. longibrachiatum MD33, resolving the hybrid pathway and establishing this fungus as a sustainable production platform for dendrobine. The dose-dependent response highlights the dual role of nanoparticle-mediated engineering in metabolic enhancement and stress induction. This integration of nanotechnology and multi-omics bridges the critical gaps in fungal biotechnology, enabling scalable and eco-friendly alkaloid synthesis. Future applications include CRISPR-AuNP genome editing and bioreactor optimization, which will advance pharmaceutical and environmental biotechnologies.

Indexed as

AlkaloidsGoldMetabolic EngineeringMetal NanoparticlesTerpenesTrichodermaBiosynthetic PathwaysAlkaloidsGoldTerpenesBiosynthetic pathway elucidationFungal secondary metabolitesHeterologous productionNano-elicitationOxidative stress modulation

Identifiers

PMID41572270
PMCPMC12910941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.